CA Stock MarketDetailed Quotes

Cosciens Biopharma Inc (AEZS)

Watchlist
  • 8.290
  • 0.0000.00%
15min DelayMarket Closed Aug 8 16:00 ET
25.38MMarket Cap-2.61P/E (TTM)

Cosciens Biopharma Inc (AEZS) Key Financial Indicators

AEZS Earnings per Share (EPS)

According to the latest financial report of Cosciens Biopharma Inc, the latest earnings per share (TTM) for the company is --. Investing in companies with strong earnings per share can potentially provide higher returns.

Quarterly

Loading...

AEZS Free Cash Flow (FCF)

Interested in knowing about Cosciens Biopharma Inc's free cash flow? The latest report shows it as --. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Quarterly

Loading...

AEZS Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Cosciens Biopharma Inc shows that the company's current ratio is --, indicating healthy liquidity.

Quarterly

Loading...

AEZS Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Cosciens Biopharma Inc, the quick ratio is --, indicating that the company can meet its short-term debt obligations.

Quarterly

Loading...

AEZS Return on Equity (ROE)

Want to learn more about the financial health of Cosciens Biopharma Inc? The latest ROE figure is --, indicating that the company has stable profitability.

Quarterly

Loading...

AEZS Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Cosciens Biopharma Inc, the total asset return on investment (ROA) is --.

Quarterly

Loading...

AEZS Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Cosciens Biopharma Inc's latest financial report to see how their gross margin is doing - currently at --.

Quarterly

Loading...

AEZS Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Cosciens Biopharma Inc, the net profit margin is --, which is a good sign for its profitability.

Quarterly

Loading...

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
The US-Iran situation has reached a major turning point as Trump announced a two-week suspension of military actions against Iran, with both Show More